PRESS RELEASE published on 01/08/2025 at 07:25, 1 year 9 months ago EQS-Adhoc: TeamViewer SE: TeamViewer exceeds FY 2024 Revenue guidance with Revenue of c. €671 million (+9% cc yoy), driven by stronger-than-expected full-year Billings of c. €700 million TeamViewer SE exceeds FY 2024 Revenue guidance with €671 million (+9% cc yoy) driven by strong full-year Billings of €700 million Preliminary Results FY 2024 Revenue Billings TeamViewer SE Development Of Sales
PRESS RELEASE published on 01/08/2025 at 07:00, 1 year 9 months ago Doubling of production capacity at the manufacturing site in Malmö PolyPeptide Group AG announces doubling of solid-phase peptide synthesis (SPPS) capacity at its manufacturing site in Malmö, Sweden, to meet growth initiatives and enhance collaboration with customers Malmö Capacity Expansion PolyPeptide Group SPPS Capacity Manufacturing Site
PRESS RELEASE published on 01/08/2025 at 07:00, 1 year 9 months ago Prodware: Calendrier financier 2025 Prodware annonce son calendrier financier pour l'année 2025 avec des dates clés de publication des chiffres d'affaires et résultats. Prochaine annonce le 13 février 2025 Chiffre D'affaires Calendrier Financier Résultats Prodware Publication
PRESS RELEASE published on 01/08/2025 at 07:00, 1 year 9 months ago Helvetia successfully places two senior bond tranches totaling CHF 250 million Helvetia successfully places two senior bond tranches totaling CHF 250 million on the Swiss capital market for general corporate purposes Bond Swiss Market Helvetia Tranches CHF 250 Million
REGULATED PRESS RELEASE published on 01/08/2025 at 07:00, 1 year 9 months ago Biophytis annonce un nouvel apport en cash et une conversion de dettes pouvant atteindre 8,6 M€ pour financer son programme dans l’obésité Biophytis annonce un nouvel apport en cash de 2,5 M€ et une conversion de dettes jusqu'à 6,1 M€ pour financer son programme dans l'obésité. Opération de refinancement de 8,6 M€ pour consolider sa structure financière et lancer l'étude de phase 2 OBA aux États-Unis Biophytis Financement Développement Clinique Opération Financière Obésité
REGULATED PRESS RELEASE published on 01/08/2025 at 07:00, 1 year 9 months ago Biophytis Announces New Cash Contribution and Debt Conversion up to €8.6 million to Finance the Obesity Program Biophytis announces new cash contribution and debt conversion totaling €8.6 million to finance obesity program. Strategic financial transaction strengthens company's financial structure for future development Biophytis Financial Transaction Debt Conversion Obesity Program Cash Contribution
REGULATED PRESS RELEASE published on 01/08/2025 at 07:00, 1 year 9 months ago Déclaration du nombre d’actions et droits de vote au 31 décembre 2024 Edenred communique le nombre d'actions et de droits de vote au 31 décembre 2024, conformément à la réglementation financière en vigueur Edenred Déclaration Droits De Vote Actions Règlement Financier
REGULATED PRESS RELEASE published on 01/08/2025 at 07:00, 1 year 9 months ago Disclosure of Share Capital and Voting Rights as of December 31, 2024 Edenred discloses share capital and voting rights as of December 31, 2024, excluding treasury shares. Detailed info at edenred.com Edenred Share Capital Voting Rights Investors Disclosure
PRESS RELEASE published on 01/08/2025 at 06:59, 1 year 9 months ago grenke achieves target with more than EUR 3 billion in lea-sing new business for 2024 grenke AG achieves target with over EUR 3 billion in leasing new business for 2024, showing significant growth in contribution margin and expanding reseller network Growth GRENKE AG Contribution Margin Leasing New Business Reseller Network
REGULATED PRESS RELEASE published on 01/08/2025 at 06:50, 1 year 9 months ago 2024/2025 First quarter Sales Trigano reports a 17.4% decrease in Q1 2025 sales due to efforts to normalize motorhome stocks. Market share increased in a buoyant European motorhome market Trigano European Market Market Share Q1 2025 Sales Motorhome Stocks
Published on 11/04/2026 at 23:10, 4 hours 55 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 5 hours 5 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 5 hours 50 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 6 hours ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 03:55, 10 minutes ago AlphaESS Named a BloombergNEF Tier 1 Energy Storage Manufacturer for the Fifth Consecutive Quarter in Q4 2026
Published on 11/05/2026 at 03:10, 55 minutes ago SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Published on 11/05/2026 at 00:02, 4 hours 3 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 8 hours 24 minutes ago EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 8 hours 40 minutes ago Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:00, 10 hours 5 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 10 hours 5 minutes ago L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:44, 10 hours 21 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026